Real-life analysis of neoadjuvant-therapy-associated benefits for pathological complete response and survival in early breast cancer patients - role of trastuzumab in HER2+ BC and platinum in TNBC

Overview of attention for article published in Frontiers in oncology, January 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 1 news outlet

twitter: 4 X users

Summary News X

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 28,452 followers.

Real-life analysis of neoadjuvant-therapy-associated benefits for pathological complete response and survival in early breast cancer patients - role of trastuzumab in HER2+ BC and platinum in TNBC https://t.co/Mq3GBuOZdW https://t.co/XiHGYTFCEN

25 Jan 2023

Reply Repost Favourite

RT @FrontOncology: New research: Real-life analysis of neoadjuvant-therapy-associated benefits for pathological complete response and survi…

25 Jan 2023

Reply Repost Favourite

RT @gedefo_sefh: Real-life analysis of neoadjuvant-therapy-associated benefits for pathological complete response and survival in early bre…

25 Jan 2023

Reply Repost Favourite

25 Jan 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.